BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31705784)

  • 1. [
    Bak-Fredslund KP; Keiding S; Villadsen GE; Kramer S; Schlander S; Sørensen M
    Liver Int; 2020 Feb; 40(2):447-455. PubMed ID: 31705784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
    Sørensen M; Frisch K; Bender D; Keiding S
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1723-31. PubMed ID: 21553087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
    Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
    Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidentally found parotid gland lesion in
    Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
    BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic metastases of hepatocellular carcinoma on
    Sarma M; Padma S; Pavithran P; Somasundaram VH; Sundaram PS
    J Egypt Natl Canc Inst; 2021 Nov; 33(1):36. PubMed ID: 34825288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of [
    John BV; Aubuchon S; Dahman B; Konjeti VR; Heuman D; Hubert J; Thomas S; Deng Y; Solomon C; Sundaram LT; Love E; Singal AG; Tatum JL
    Liver Transpl; 2020 Jun; 26(6):774-784. PubMed ID: 32128966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
    J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.
    Horsager J; Bak-Fredslund K; Larsen LP; Villadsen GE; Bogsrud TV; Sørensen M
    EJNMMI Res; 2016 Dec; 6(1):56. PubMed ID: 27341819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced modulation of glucose transporter expression impacts
    Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
    Ali SA; Amin DH; Abdelkhalek YI
    Jpn J Radiol; 2020 May; 38(5):472-479. PubMed ID: 32078123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
    Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
    J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
    Wang XL; Li H; Wang QS; Zhang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
    Lee JE; Jang JY; Jeong SW; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY; Choi DL
    World J Gastroenterol; 2012 Jun; 18(23):2979-87. PubMed ID: 22736922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.